Tony Besse
Senior Associate, HealthTech
Tony focuses on finding HealthTech opportunities at Oxford Science Enterprises, as well as supporting venture creation, and working with portfolio companies.
He joined in 2023 from Bain & Company, where he advised Private Equity clients on value creation and due diligence across healthcare and industrials. He also brings experience from Bernstein’s Equity Research teams in MedTech and Specialty Pharma, and earlier worked at Applied Predictive Technologies, a software analytics firm later acquired by Mastercard.
Tony holds an MBA from INSEAD and an MPhysPhil in Physics and Philosophy from the University of Oxford.
WORK WITH US
Oxford researchers & innovators
Want your research to have real-world impact?
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.
Investors
Interested in becoming an OSE shareholder?
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.
Co-investors
Looking to invest in Oxford’s most exciting spinouts?
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.